The emergence of neoadjuvant therapy in advanced melanoma

被引：11

作者：

Sun, James ^{[1
]}

Kirichenko, Dennis A. ^{[2
]}

Zager, Jonathan S. ^{[1
]}

Eroglu, Zeynep ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA

[2] Univ S Florida, Morsani Coll Med, Tampa, FL 33612 USA

来源：

MELANOMA MANAGEMENT | 2019年 / 6卷 / 03期

关键词：

advanced melanoma; biochemotherapy; immunotherapy; intralesional therapy; melanoma; metastatic melanoma; neoadjuvant; oncolyticvirus; targeted therapy; HIGH RESPONSE RATE; PHASE-III TRIAL; STAGE-III; METASTATIC MELANOMA; OPEN-LABEL; HIGH-RISK; BIOCHEMOTHERAPY; INTERLEUKIN-2; DACARBAZINE; COMBINATION;

D O I：

10.2217/mmt-2019-0007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The discovery of immunotherapy and targeted therapy has introduced new and effective treatment options for advanced melanoma, providing therapeutic options where none existed before. The natural extension of these novel therapies is to identify their role in the neoadjuvant setting. Neoadjuvant therapy for advanced melanoma is still in its infancy, with a wealth of clinical trials underway. Early results are promising, allowing for management of a disease that previously had few options. We review the current literature and interim results from several ongoing investigations to understand the current state of neoadjuvant treatment options and what is to come. These studies pave the way for further advancements in melanoma therapy.

引用

页数：11

共 44 条

[1] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma [J].

Amaria, Rodabe N. ;

Reddy, Sangeetha M. ;

Tawbi, Hussein A. ;

Davies, Michael A. ;

Ross, Merrick, I ;

Glitza, Isabella C. ;

Cormier, Janice N. ;

Lewis, Carol ;

Hwu, Wen-Jen ;

Hanna, Ehab ;

Diab, Adi ;

Wong, Michael K. ;

Royal, Richard ;

Gross, Neil ;

Weber, Randal ;

Lai, Stephen Y. ;

Ehlers, Richard ;

Blando, Jorge ;

Milton, Denai R. ;

Woodman, Scott ;

Kageyama, Robin ;

Wells, Daniel K. ;

Hwu, Patrick ;

Patel, Sapna P. ;

Lucci, Anthony ;

Hessel, Amy ;

Lee, Jeffrey E. ;

Gershenwald, Jeffrey ;

Simpson, Lauren ;

Burton, Elizabeth M. ;

Posada, Liberty ;

Haydu, Lauren ;

Wang, Linghua ;

Zhang, Shaojun ;

Lazar, Alexanderj ;

Hudgens, Courtney W. ;

Gopalakrishnan, Vancheswaran ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Spencer, Christine N. ;

Prieto, Victor ;

Sharma, Padmanee ;

Allison, James ;

Tetzlaff, Michael T. ;

Wargo, Jennifer A. .

NATURE MEDICINE, 2018, 24 (11) :1649-+

[2] Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial [J].

Amaria, Rodabe N. ;

Prieto, Peter A. ;

Tetzlaff, Michael T. ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Ross, Merrick J. ;

Glitza, Isabella C. ;

Cormier, Janice ;

Hwu, Wen-Jen ;

Tawbi, Hussein A. ;

Patel, Sapna P. ;

Lee, Jeffrey E. ;

Gersbenwaid, Jeffrey E. ;

Spencer, Christine N. ;

Gopalakrishnan, Vancheswaran ;

Bassett, Roland ;

Simpson, Lauren ;

Mouton, Rosalind ;

Hudgens, Courtney W. ;

Zhao, Li ;

Zhu, Haifeng ;

Cooper, Zachary A. ;

Wani, Khalida ;

Lazar, Alexander ;

Hwu, Patrick ;

Diab, Adi ;

Wong, Michael K. ;

McQuade, Jennifer L. ;

Royal, Richard ;

Lucci, Anthony ;

Burton, Elizabeth M. ;

Reddy, Sangeetha ;

Sharma, Padmanee ;

Allison, James ;

Futreal, Phillip A. ;

Woodman, Scott E. ;

Davies, Michael A. ;

Wargo, Jennifer A. .

LANCET ONCOLOGY, 2018, 19 (02) :181-193

[3] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].

Andtbacka, Robert H. I. ;

Kaufman, Howard L. ;

Collichio, Frances ;

Amatruda, Thomas ;

Senzer, Neil ;

Chesney, Jason ;

Delman, Keith A. ;

Spitler, Lynn E. ;

Puzanov, Igor ;

Agarwala, Sanjiv S. ;

Milhem, Mohammed ;

Cranmer, Lee ;

Curti, Brendan ;

Lewis, Karl ;

Ross, Merrick ;

Guthrie, Troy ;

Linette, Gerald P. ;

Daniels, Gregory A. ;

Harrington, Kevin ;

Middleton, Mark R. ;

Miller, Wilson H., Jr. ;

Zager, Jonathan S. ;

Ye, Yining ;

Yao, Bin ;

Li, Ai ;

Doleman, Susan ;

VanderWalde, Ari ;

Gansert, Jennifer ;

Coffin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98

[4] Trial in progress: A phase 2 study of intratumor pil-12 plus electroporation in combination with intravenous pembrolizumab in patients with stage III/IV mealanoma progressing on either pembrolizumab or nivolumab treatment (PISCES) [J].

Andtbacka, Robert Hans Ingemar ;

Van Hagen, Tom ;

Parente, Phillip ;

Atkinson, Victoria ;

Puzanov, Igor ;

Daniels, Gregory A. ;

Thomas, Sajeve Samuel ;

Loncg, Anne Poh ;

Haydon, Andrew Mark ;

Dudek, Arkadiusz Z. ;

Gargosky, Sharron Erna ;

Twitty, Chris ;

Kirkwood, John M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[5]

[Anonymous], 2017, ANN ONCOL S5

[6] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].

Blank, Christian U. ;

Rozeman, Elisa A. ;

Fanchi, Lorenzo F. ;

Sikorska, Karolina ;

van de Wiel, Bart ;

Kvistborg, Pia ;

Krijgsman, Oscar ;

van den Braber, Marlous ;

Philips, Daisy ;

Broeks, Annegien ;

van Thienen, Johannes, V ;

Mallo, Henk A. ;

Adriaansz, Sandra ;

ter Meulens, Sylvia ;

Pronk, Loes M. ;

Grijpink-Ongering, Lindsay G. ;

Bruining, Annemarie ;

Gittelman, Rachel M. ;

Warren, Sarah ;

van Tinteren, Harm ;

Peeper, Daniel S. ;

Haanen, John B. A. G. ;

van Akkooi, Alexander C. J. ;

Schumacher, Ton N. .

NATURE MEDICINE, 2018, 24 (11) :1655-+

[7]

Blankenstein S, 2018, ANN ONCOL S8, V29, pviii442

[8] Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases [J].

Buzaid, AC ;

Colome, M ;

Bedikian, A ;

Eton, O ;

Legha, SS ;

Papadopoulos, N ;

Plager, C ;

Ross, M ;

Lee, JE ;

Mansfield, P ;

Rice, J ;

Ring, S ;

Lee, JJ ;

Strom, E ;

Benjamin, R .

MELANOMA RESEARCH, 1998, 8 (06) :549-556

[9] Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study [J].

Danielli, Riccardo ;

Patuzzo, Roberto ;

Di Giacomo, Anna Maria ;

Gallino, Gianfranco ;

Maurichi, Andrea ;

Di Florio, Annabella ;

Cutaia, Ornella ;

Lazzeri, Andrea ;

Fazio, Carolina ;

Miracco, Clelia ;

Giovannoni, Leonardo ;

Elia, Giuliano ;

Neri, Dario ;

Maio, Michele ;

Santinami, Mario .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (08) :999-1009

[10] High response rate to PD-1 blockade in desmoplastic melanomas [J].

Eroglu, Zeynep ;

Zaretsky, Jesse M. ;

Hu-Lieskovan, Siwen ;

Kim, Dae Won ;

Algazi, Alain ;

Johnson, Douglas B. ;

Liniker, Elizabeth ;

Kong, Ben ;

Munhoz, Rodrigo ;

Rapisuwon, Suthee ;

Gherardini, Pier Federico ;

Chmielowski, Bartosz ;

Wang, Xiaoyan ;

Shintaku, I. Peter ;

Wei, Cody ;

Sosman, Jeffrey A. ;

Joseph, Richard W. ;

Postow, Michael A. ;

Carlino, Matteo S. ;

Hwu, Wen-Jen ;

Scolyer, Richard A. ;

Messina, Jane ;

Cochran, Alistair J. ;

Long, Georgina V. ;

Ribas, Antoni .

NATURE, 2018, 553 (7688) :347-+

← 1 2 3 4 5 →